Intraoperative radiation therapy for pediatric sarcomas and other solid tumors Journal Article
| Authors: | Conte, B.; Casey, D. L.; Tringale, K. R.; LaQuaglia, M. P.; Gerstle, J. T.; Wexler, L.; Ortiz, M. V.; Wolden, S. L. |
| Article Title: | Intraoperative radiation therapy for pediatric sarcomas and other solid tumors |
| Abstract: | Purpose: To evaluate local failure (LF) and toxicity after intraoperative radiation therapy (IORT) in pediatric solid tumors (ST). Methods: A single-institution retrospective study of 96 pediatric patients (108 applications) with ST treated from 1995 to 2022 with IORT. LF was calculated via cumulative incidence function and overall survival (OS) by Kaplan–Meier method, both from the day of surgery. Results: Median age at time of IORT was 8 years (range: 0.8–20.9 years). Median follow-up for all patients and surviving patients was 16 months and 3 years, respectively. The most common histologies included rhabdomyosarcoma (n = 42), Ewing sarcoma (n = 10), and Wilms tumor (n = 9). Most (95%) received chemotherapy, 37% had prior external beam radiation therapy to the site of IORT, and 46% had a prior surgery for tumor resection. About half (54%) were treated with upfront IORT to the primary tumor due to difficult circumstances such as very young age or challenging anatomy. The median IORT dose was 12 Gy (range: 4–18 Gy), and median area treated was 24 cm2 (range: 2–198 cm2). The cumulative incidence of LF was 17% at 2 years and 23% at 5 years. Toxicity from IORT was reasonable, with postoperative complications likely related to IORT seen in 15 (16%) patients. Conclusion: Our study represents the largest and most recent analysis of efficacy and safety of IORT in pediatric patients with ST. Less than one quarter of all patients failed locally with acceptable toxicities. Overall, IORT is an effective and safe technique to achieve local control in patients with challenging circumstances. © 2024 Wiley Periodicals LLC. |
| Keywords: | adolescent; child; clinical article; controlled study; cancer surgery; primary tumor; major clinical study; overall survival; solid tumor; follow up; radiotherapy; retrospective study; histology; ewing sarcoma; sarcoma; postoperative complication; surgery; external beam radiotherapy; rhabdomyosarcoma; drug therapy; sarcomas; therapy; nephroblastoma; intraoperative radiotherapy; wilms tumor; intraoperative radiation therapy; human; male; female; article; pediatric patient; special situation for pharmacovigilance |
| Journal Title: | Pediatric Blood and Cancer |
| Volume: | 71 |
| Issue: | 6 |
| ISSN: | 1545-5009 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2024-06-01 |
| Start Page: | e30949 |
| Language: | English |
| DOI: | 10.1002/pbc.30949 |
| PUBMED: | 38520048 |
| PROVIDER: | scopus |
| PMCID: | PMC11984314 |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work